TREA

79339202 - BYLOK

Follow

Information

  • Trademark
  • 79339202
  • Serial Number
    79339202
  • Registration Number
    6938347
  • Filing Date
    February 01, 2022
    2 years ago
  • Registration Date
    January 03, 2023
    a year ago
  • Transaction Date
    September 17, 2024
    2 months ago
  • Status Date
    January 03, 2023
    a year ago
  • Published for Opposition Date
    October 18, 2022
    2 years ago
  • Location Date
    January 03, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DAWE III, BILL
  • Attorney Docket Number
    6665.149943
    Attorney Name
    LAWRENCE J CRAIN
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BYLOK
Case File Statements
  • GS0091: Downloadable computer software for scientific laboratory research and commercial use for applications with monoclonal or trimeric antibodies used to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases, namely, software for an algorithm to generate antibody sequences
  • GS0051: Pharmaceutical preparations based on human monoclonal or trimeric antibodies and derivatives thereof for treating cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases, for use in related diagnostic or therapeutic use, and for use as medical diagnostic assays for testing of body fluids or tissues, for use in disease detection, including, cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases
  • GS0451: Legal services in the field of patent exploitation, namely, patent licensing; licensing of intellectual property in the field of monoclonal and trimeric antibodies for laboratories, diagnostics and analytics for scientific or research use
  • GS0011: Biochemicals, namely, monoclonal and trimeric antibodies and derivatives thereof for in-vivo or in-vitro scientific research and development to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases and for use in laboratories, diagnostics and analytics for scientific or research use
  • GS0421: Medical and scientific research in the fields of human monoclonal or trimeric antibodies to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases; medical research services, namely, protein engineering in the fields of human monoclonal or trimeric antibodies to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases; pharmaceutical product development in the fields of human monoclonal or trimeric antibodies to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases; industrial research in the fields of human monoclonal or trimeric antibodies to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases; and contract research services in the fields of human monoclonal or trimeric antibodies to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases; computer programming for acquisition and processing of medical data in the context of medical-scientific research, development and therapy with monoclonal or trimeric antibodies and their derivatives
Case File Event Statements
  • 7/28/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/1/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 9/9/2022 - 2 years ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/28/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 4/29/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/3/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/2/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/3/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 8/31/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/9/2022 - 2 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/10/2022 - 2 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/13/2022 - 2 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/21/2022 - 2 years ago
    13 - REFUSAL PROCESSED BY IB Type: RFNP
  • 9/28/2022 - 2 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/18/2022 - 2 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/18/2022 - 2 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/3/2023 - a year ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/3/2023 - a year ago
    18 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/3/2023 - a year ago
    19 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/20/2023 - a year ago
    20 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 5/17/2023 - a year ago
    22 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 9/12/2024 - 2 months ago
    23 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/12/2024 - 2 months ago
    24 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/12/2024 - 2 months ago
    25 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/20/2023 - a year ago
    21 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS